Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.19.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Product revenue $ 0 $ 0
Cost of product revenue 0 0
Gross profit 0 0
Operating expenses:    
Research and development 871,742 715,841
General and administrative 3,439,882 3,511,809
Sales and marketing 0 0
Total operating expenses 4,311,624 4,227,650
Loss from continuing operations before interest (4,311,624) (4,227,650)
Interest income, net 40,021 17,588
Loss from continuing operations (4,271,603) (4,210,062)
Loss from discontinued operations (3,633,386) (6,225,036)
Net loss $ (7,904,989) $ (10,435,098)
Loss from continuing operations per share – basic and fully diluted $ (0.30) $ (0.32)
Loss from discontinued operations per share – basic and fully diluted (0.26) (0.47)
Net loss per share – basic and fully diluted $ (0.56) $ (0.79)
Weighted average number of shares outstanding – basic and fully diluted 13,997,444 13,223,229